15 completed, 6 unknown, 5 recruiting, 2 not yet recruiting. 30 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 30 | Completed 15, Unknown 6, Recruiting 5, Not yet recruiting 2, Enrolling by invitation 1, Terminated 1 |
Follow Atherosclerosis: new trials by email Literature Review of Atherosclerosis trials Research Report on Atherosclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion Vitamin B6 25 MG, Vitamin B6 50 MG, Vitamin B6 100 MG - Ischemia Reperfusion Injury, Peripheral Artery Disease | Early Phase 1 | Not yet recruiting | Milton S. Hershey Medical Center | 30 | 2027-12-01 | 2026-03-17 |
| Study to Image Inflammatory Activity of a Fluorescence Imaging Agent in Excised Human Artery Plaques Pegulicianine, Placebo - Carotid Artery Diseases, Peripheral Arterial Disease | Early Phase 1 | Not yet recruiting | Massachusetts General Hospital | 25 | 2027-06-01 | 2026-11-10 |
| PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With 64Cu-NODAGA-CANF (Volunteer - Dosimetry Study) 64Cu-NODAGA-CANF - Healthy Adult, Healthy | Early Phase 1 | Recruiting | Washington University School of Medicine | 8 | 2026-08-19 | 2026-09-02 |
| Truway Diagnostic Tools in Primary Care Truway Portable Ultrasound Device, Truway Blood Glucose Monitor, Standard Oral Hypoglycemic Agent - Chronic Disease, Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight | Early Phase 1 | Enrolling by invitation | Truway Health, Inc. | 200 | 2025-10-01 | 2026-11-05 |
| A Clinical Study of IMC-001 for Injection in Improving Atherosclerotic Plaque Stability in Patients With Acute Coronary Syndrome. IMC-001 and Optimal medical treatment, IMC-001 placebo and optimal medical treatment - Atherosclerosis | Early Phase 1 | Recruiting | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 18 | 2025-03-10 | 2026-04-15 |
| Placebo-controlled Study of Single and Multiple Ascending Doses of UDP-003 in Healthy Human Participants and Followed by an Open-label Patient Cohort UDP-003, Placebo - Atherosclerotic Cardiovascular Disease, Acute Coronary Syndromes | Early Phase 1 | Recruiting | Cyclarity Therapeutics, Inc. | 84 | 2025-02-25 | 2026-09-25 |
| Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease Vumerity, Placebo - Peripheral Artery Disease, Peripheral Vascular Diseases | Early Phase 1 | Recruiting | University of Nebraska | 20 | 2024-11-14 | 2026-06-24 |
| Mechanistic Clinical Trial of Colchicine in Patients With Peripheral Artery Disease Colchicine, Placebo - Peripheral Artery Disease | Early Phase 1 | Completed | University of Pennsylvania | 24 | 2024-09-25 | 2026-04-02 |
| Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography) [89Zr]Zr-DFO-APAC, PET/CT scan - Peripheral Arterial Occlusive Disease, Critical Limb Ischemia | Early Phase 1 | Unknown | Aplagon Oy | 10 | 2024-02-01 | 2025-01-30 |
| Umbilical Cord Artery-derived Perivascular Stem Cells for the Critical Limb Ischemia Therapy UCA-PSCs/bFGF or bFGF Intramuscular injection - Critical Limb Ischemia | Early Phase 1 | Unknown | Nanjing University | 40 | 2023-06-30 | 2023-12-18 |
| Outcomes of Rivaroxaban and Aspirin in PAD After Endovascular Revascularization Rivaroxaban and Aspirin - Peripheral Arterial Disease | Early Phase 1 | Unknown | Assiut University | 100 | 2022-08-01 | 2022-07-20 |
| 68Ga-FAPI PET/MR for Atherosclerosis 68Ga-FAPI - Atherosclerosis | Early Phase 1 | Unknown | Peking Union Medical College Hospital | 100 | 2021-05-26 | 2021-09-08 |
| A Genomic Approach for Clopidogrel in Caribbean Hispanics CYP2C19 test, P2RY12 assay - Cardiovascular Disease (CVD), Stroke | Early Phase 1 | Completed | University of Puerto Rico | 150 | 2020-09-01 | 2026-06-02 |
| Ertugliflozin: Cardioprotective Effects on Epicardial Fat Ertugliflozin - Cardiovascular Diseases, Atherosclerosis | Early Phase 1 | Completed | Stanford University | 61 | 2020-07-01 | 2026-06-04 |
| Ultrasound Evaluation of Lower Extremity Arteries After Topical Nitroglycerin Administration Nitroglycerin Topical Product - Peripheral Arterial Disease | Early Phase 1 | Unknown | Deborah Heart and Lung Center | 80 | 2019-12-30 | 2019-11-08 |
| Nutrition in Patient With Critical Limb Ischemia Ensure Surgery Immunonutrition Shake, Ensure Enlive Advanced Nutrition Shake - Critical Limb Ischemia, Malnutrition | Early Phase 1 | Recruiting | Boston Medical Center | 30 | 2018-10-02 | 2026-09-29 |
| The Effect of Prednisone on Atherogenesis as Studied in the Macrophage Foam Cell Formation Model System. Prednisone 20 Mg, Prednisone 40 Mg - Atherosclerosis, Dyslipidemias | Early Phase 1 | Completed | Prof. Tony hayek MD | 10 | 2018-01-17 | 2019-02-21 |
| PPG Project 3 - PET/MRI of the Brain-hematopoiesis-atherosclerosis Axis in PTSD Patients fluorodeoxyglucose (FDG)-PET/MRI - PTSD, Trauma | Early Phase 1 | Completed | Zahi Fayad | 190 | 2017-11-28 | 2023-04-14 |
| Angiotensin-(1-7) in Peripheral Arterial Disease Angiotensin 1-7, Saline - Peripheral Arterial Disease | Early Phase 1 | Terminated | Milton S. Hershey Medical Center | 6 | 2017-09-01 | 2024-05-03 |
| N-Acetyl-Cysteine (NAC) for Healing of Amputation Stumps in the Setting of Diabetes Active Arm N-acetyl cysteine (NAC), Placebo Arm - Diabetes Mellitus, Critical Limb Ischemia | Early Phase 1 | Completed | Washington University School of Medicine | 33 | 2017-03-01 | 2024-08-16 |
Showing 20 of 30. Sign in to see all of them.
Peripheral Arterial Disease (15) · Chronic Limb-Threatening Ischemia (5) · Cardiovascular Diseases (4) · Acute Coronary Syndrome (3) · Diabetes Mellitus (3) · Diabetes Mellitus, Type 2 (2) · Inflammation (2) · Peripheral Arterial Occlusive Disease 1 (2) · Carotid Artery Diseases (1) · Chronic Disease (1) · Coronary Artery Disease (1) · Dyslipidemias (1) · Hyperlipidemias (1) · Hypertension (1)
Arterial Occlusive Diseases (30) · Arteriosclerosis (30) · Vascular Diseases (30) · Cardiovascular Diseases (26) · Peripheral Vascular Diseases (17) · Pathologic Processes (10) · Pathological Conditions, Signs and Symptoms (10) · Disease Attributes (6) · Ischemia (6) · Chronic Disease (5) · Nutritional and Metabolic Diseases (5) · Endocrine System Diseases (4) · Glucose Metabolism Disorders (4) · Metabolic Diseases (4)
Rosuvastatin Calcium (2) · 68Ga-FAPI (1) · Acetates (1) · Acetylcysteine (1) · Aspirin (1) · Chelation Therapy (1) · Colchicine (1) · Edetic Acid (1) · Ezetimibe, Simvastatin Drug Combination (1) · Fluorodeoxyglucose F18 (1) · Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent (1) · IMC-001 (1) · Losartan (1) · Pioglitazone (1) · Prednisone (1)
Washington University School of Medicine (3) · AstraZeneca (2) · Milton S. Hershey Medical Center (2) · Peking Union Medical College Hospital (2) · Aplagon Oy (1) · Arkansas Heart Hospital (1) · Assiut University (1) · Augusta University (1) · Boston Medical Center (1) · Cyclarity Therapeutics, Inc. (1) · Deborah Heart and Lung Center (1) · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1) · Kurume University (1) · Massachusetts General Hospital (1) · Medtronic Endovascular (1)
United States (13) · China (4) · Sweden (2) · Australia (1) · Canada (1) · Israel (1) · Japan (1) · Netherlands (1) · Puerto Rico (1)
Amy C Arnold, PhD (1) · David Kandzari, MD (1) · Gervasio Lamas, MD (1) · Guillermo Tearney, MD, PhD (1) · Gwenael Layec, PhD (1) · Haiming Xia, phD (1) · Jeffrey J Siracuse, MD (1) · Jorge Duconge, PhD (1) · Jun Pu, M.D. (1) · Lu Qin (1) · Maria Leonsson-Zachrissson, MD (1) · Maria Leonsson-Zachrissson, MD, Study Physician (1) · Meiqi Wu, M.D. (1)
PMID 34415683, PMID 35129469, PMID 37761953, PMID 37873439, PMID 38106133, PMID 39242160
2023 (1), P01HL131478 (1), R01HL159803 (1), R01HL165453 (1), U54MD007600 (1)